- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 478052, 6 pages
The Average IFN-γ Secreting Capacity of Specific CD8+ T Cells Is Compromised While Increasing Copies of a Single T Cell Epitope Encoded by DNA Vaccine
1Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
2Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China
3Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, Fudan University, Shanghai 200032, China
4School of Biology and Basic Medical Sciences, Soochow University, Suzhou 215123, China
Received 20 July 2012; Revised 24 September 2012; Accepted 25 September 2012
Academic Editor: Bapi Pahar
Copyright © 2012 Yanmin Wan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- S. Sadanand, “Vaccination: the present and the future,” Yale Journal of Biology and Medicine, vol. 84, no. 4, pp. 353–359, 2011.
- A. Sette, M. Newman, B. Livingston et al., “Optimizing vaccine design for cellular processing, MHC binding and TCR recognition,” Tissue Antigens, vol. 59, no. 6, pp. 443–451, 2002.
- A. Sette, E. Keogh, G. Ishioka et al., “Epitope identification and vaccine design for cancer immunotherapy,” Current Opinion in Investigational Drugs, vol. 3, no. 1, pp. 132–139, 2002.
- A. Sette and J. Fikes, “Epitope-based vaccines: an update on epitope identification, vaccine design and delivery,” Current Opinion in Immunology, vol. 15, no. 4, pp. 461–470, 2003.
- L. Guo, K. Liu, G. Xu, et al., “Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model,” Applied Microbiology and Biotechnology, vol. 95, no. 6, pp. 1437–1444, 2012.
- S. Iurescia, D. Fioretti, V. M. Fazio, and M. Rinaldi, “Design and pre-clinical development of epitope-based DNA vaccines against B-cell lymphoma,” Current Gene Therapy, vol. 11, no. 5, pp. 414–422, 2011.
- G. Y. Ishioka, J. Fikes, G. Hermanson et al., “Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes,” Journal of Immunology, vol. 162, no. 7, pp. 3915–3925, 1999.
- K. Anderson, P. Cresswell, M. Gammon, J. Hermes, A. Williamson, and H. Zweerink, “Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis,” Journal of Experimental Medicine, vol. 174, no. 2, pp. 489–492, 1991.
- J. Alexander, M. F. Del Guercio, A. Maewal et al., “Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses,” Journal of Immunology, vol. 164, no. 3, pp. 1625–1633, 2000.
- B. D. Livingston, M. Newman, C. Crimi, D. McKinney, R. Chesnut, and A. Sette, “Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines,” Vaccine, vol. 19, no. 32, pp. 4652–4660, 2001.
- D. Li, S. Hua, Y. Fan et al., “DNA vaccine expressing repeated carcinoembryonic antigen (CEA)625-667 induces strong immunity in mice,” Immunology Letters, vol. 135, no. 1-2, pp. 124–128, 2011.
- S. C. Derrick, I. M. Yabe, A. Yang, and S. L. Morris, “Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells,” Vaccine, vol. 29, no. 16, pp. 2902–2909, 2011.
- P. Shooshtari, E. S. Fortuno, D. Blimkie et al., “Correlation analysis of intracellular and secreted cytokines via the generalized integrated mean fluorescence intensity,” Cytometry Part A, vol. 77, no. 9, pp. 873–880, 2010.
- P. A. Darrah, D. T. Patel, P. M. De Luca et al., “Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major,” Nature Medicine, vol. 13, no. 7, pp. 843–850, 2007.
- J. Xu, L. Ren, X. Huang et al., “Sequential priming and boosting with heterologous HIV immunogens predominantly stimulated T cell immunity against conserved epitopes,” AIDS, vol. 20, no. 18, pp. 2293–2303, 2006.
- M. D. Hesse, A. Y. Karulin, B. O. Boehm, P. V. Lehmann, and M. Tary-Lehmann, “A T cell clone's avidity is a function of its activation state,” Journal of Immunology, vol. 167, no. 3, pp. 1353–1361, 2001.
- S. A. Plotkin, “Correlates of vaccine-induced immunity,” Clinical Infectious Diseases, vol. 47, no. 3, pp. 401–409, 2008.
- N. Shulman, M. Bellew, G. Snelling et al., “Development of an automated analysis system for data from flow cytometric intracellular cytokine staining assays from clinical vaccine trials,” Cytometry Part A, vol. 73, no. 9, pp. 847–856, 2008.
- M. Hofmann, M. Radsak, G. Rechtsteiner et al., “T cell avidity determines the level of CTL activation,” European Journal of Immunology, vol. 34, no. 7, pp. 1798–1806, 2004.